SMI Expanded
1.731,13
PKT
-8,59
PKT
-0,49
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.07.12 | Clariant buy | Vontobel Research | |
| 09.07.12 | Galenica hold | Vontobel Research | |
| 06.07.12 | UBS overweight | HSBC | |
| 06.07.12 | Swiss Re neutral | HSBC | |
| 06.07.12 | UBS overweight | HSBC | |
| 06.07.12 | Barry Callebaut neutral | UBS AG | |
| 06.07.12 | Temenos neutral | UBS AG | |
| 06.07.12 | Barry Callebaut buy | Société Générale Group S.A. (SG) | |
| 06.07.12 | SGS SA buy | Vontobel Research | |
| 05.07.12 | Novartis buy | Deutsche Bank AG | |
| 05.07.12 | Barry Callebaut neutral | Sarasin Research | |
| 05.07.12 | Swiss Re hold | Société Générale Group S.A. (SG) | |
| 05.07.12 | Barry Callebaut hold | Vontobel Research | |
| 05.07.12 | SGS SA buy | Vontobel Research | |
| 05.07.12 | Kühne + Nagel International hold | Vontobel Research | |
| 04.07.12 | Swiss Re neutral | Exane-BNP Paribas SA | |
| 04.07.12 | Holcim sell | Goldman Sachs Group Inc. | |
| 04.07.12 | Holcim neutral | Goldman Sachs Group Inc. | |
| 04.07.12 | Clariant hold | Deutsche Bank AG | |
| 04.07.12 | Givaudan sell | Deutsche Bank AG | |
| 04.07.12 | Kühne + Nagel International overweight | J.P. Morgan Cazenove | |
| 03.07.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 03.07.12 | Temenos outperform | Exane-BNP Paribas SA | |
| 03.07.12 | Zurich Insurance buy | Nomura | |
| 03.07.12 | Swiss Re buy | Sarasin Research | |
| 03.07.12 | Nestlé kaufen | Norddeutsche Landesbank (Nord/LB) | |
| 03.07.12 | Kühne + Nagel International hold | Vontobel Research | |
| 02.07.12 | Nestlé neutral | Goldman Sachs Group Inc. | |
| 02.07.12 | Geberit kaufen | Euro am Sonntag | |
| 02.07.12 | Julius Bär buy | ING | |
| 02.07.12 | UBS hold | ING | |
| 02.07.12 | UBS sell | ING | |
| 02.07.12 | Swisscom hold | Vontobel Research | |
| 02.07.12 | Schindler kaufen | Die Actien-Börse | |
| 02.07.12 | SGS SA kaufen | Die Actien-Börse | |
| 29.06.12 | Nestlé sector perform | RBC Capital Markets | |
| 29.06.12 | Barry Callebaut sell | Société Générale Group S.A. (SG) | |
| 28.06.12 | Roche buy | Deutsche Bank AG | |
| 28.06.12 | Novartis buy | Deutsche Bank AG | |
| 28.06.12 | UBS neutral | Sarasin Research |